Central nervous system Aspergillus fumigatus presenting as cranial nerve palsy in a patient with ankylosing spondylitis on anti-TNF therapy

Rheumatology

Volumn 47, Issue 5, 2008, Pages 739-740

  Slusher, J R ^a   Maldonado, M E ^b,c   Mousavi, F ^a   Lozada, C J ^b,d  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ETANERCEPT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ANTIBODY; VORICONAZOLE;

ABDUCENS NERVE PARALYSIS; ADULT; ANKYLOSING SPONDYLITIS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN BIOPSY; BRAIN NECROSIS; CASE REPORT; CAVERNOUS SINUS; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; CRANIOTOMY; DEBRIDEMENT; DECOMPRESSION SURGERY; DISEASE DURATION; DISEASE SEVERITY; DRUG RESPONSE; DRUG WITHDRAWAL; FACE PAIN; FEVER; GRANULATION TISSUE; HEARING IMPAIRMENT; HUMAN; INFLAMMATION; INNER EAR; LETTER; LUNG FIBROSIS; MALE; MIDDLE CRANIAL FOSSA; NEGRO; NIGHT SWEAT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; PARIETAL LOBE; PRIORITY JOURNAL; TISSUE CULTURE; TRIGEMINAL NERVE DISEASE; TROCHLEAR NERVE DISEASE; VESTIBULOCOCHLEAR NERVE DISEASE; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CRANIAL NERVE DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42949154170     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken088     Document Type: Letter

References (10)

1. Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. New Engl J Med 2002;346:1349-56.
2. Kamberi M, Brummer E, Stevens DA. Regulation of bronchoalveolar macrophage proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony-stimulating factor after stimulation by Aspergillus conidia or lipopolysaccharide. Cytokine 2002;19:14-20.
3. Mehrad B, Strieter RM, Standiford TJ. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol 1999;162:1633-40.
4. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26:781-803.
5. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006;173:707-17.
6. Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: A 20-year retrospective series. Hum Pathol 2002;33:116-24.
7. Warris A, Bjorneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001;344:1099-100.
8. De Rosa FG, Shaz D, Campagna AC, Dellaripa PF, Khettry U, Craven DE. Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: A possible healthcare-associated case? Infect Control Hosp Epidemiol 2003;24:477-82.
9. Lassoued S, Sire S, Farny M, Billey T, Lassoued K. Pulmonary aspergillosis in a patient with rheumatoid arthritis treated by etanercept. Clin Exp Rheumatol 2004; 22:267-8.
10. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonist. Clin Infec Dis 2004;38:1261-5.